What This Top Dividend Portfolio Is Holding Now: AstraZeneca plc, HSBC Holdings plc And Vodafone Group plc

HSBC Holdings plc (LON:HSBA), AstraZeneca plc (LON:AZN) and Vodafone Group plc (LON:VOD) are heavyweight holdings of JP Morgan Claverhouse Investment Trust (LON:JCH).

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

JP Morgan Claverhouse IT (LSE: JCH) has a record of 41 consecutive years of dividend increases. At a current share price of 582p, the trust is on a trailing yield of 3.4%.

Picking great dividend shares has helped JP Morgan Claverhouse outperform the FTSE All-Share Index over the past three, five and 10 years.

Sectors in which the trust is currently overweight against the index include financials, healthcare and telecoms. The trust’s three biggest holdings in these three sectors are: HSBC (LSE: HSBA) (NYSE: HSBC.US), AstraZeneca (LSE: AZN) and Vodafone (LSE: VOD).

HSBC

Banking giant HSBC may have ditched its advertising slogan “The World’s Local Bank” a couple of years ago, but it has remained a convenient tag for financial hacks like me to emphasise the group’s global reach.

Geographical diversification helped HSBC get through the 2008/9 financial crisis. And while the company did reduce its dividend during those dark days, the payout has been growing at a good clip since, including a 9% rise for 2013.

City analysts are expecting a more modest 4% increase this year, followed by a 7% uplift for 2015. The recent market sell-off has seen HSBC’s shares hit a 52-week low of 589p, pushing the forward dividend yield up to a juicy 5.5% for investors today.

AstraZeneca

It’s been a good year for shareholders of AstraZeneca. The shares, which started the year at 3,600p, are currently trading at 4,427p on the back of the company’s strengthening drugs pipeline and management’s confident rejection of a 5,500p takeover offer from US pharma giant Pfizer.

The improving outlook hasn’t yet fed through to a rising dividend. Analysts are expecting the 2014 payout to be pegged at $2.80 for a fourth consecutive year, and for there to be little, if any, increase in 2015.

Nevertheless, the sterling translation of the dollar dividend equates to a yield of 4%, which is comfortably above the FTSE 100 average of 3.5%. And we could see the payout begin to rise pretty strongly further down the line.

Vodafone

Vodafone has been in a period of transition since selling its stake in US phones firm Verizon Wireless to Verizon Communications for £84bn earlier this year. The mobile giant’s earnings won’t — for at least a couple of years — cover the rising dividends the company hopes to pay.

Nevertheless, management reckons it can afford to lift the annual payouts, and signalled its confidence by raising the company’s recent interim dividend by 2%. If that carries through to the final dividend, as City analysts expect, we’d be looking at a forward yield of around 5.3% at a current share price of 213p.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended HSBC Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A young Asian woman holding up her index finger
Investing Articles

Don’t miss this once-in-a-decade opportunity to profit from the stock market’s AI hype

Our writer considers a rare value opportunity that could emerge if AI hype leads to a siginficant stock market correction.…

Read more »

A senior man using hiking poles, on a hike on a coastal path along the coastline of Cornwall.
Investing Articles

£10,000 invested in easyJet shares on 1 April is now worth…

It's been a strange month for easyJet shares. But what exactly would have happened to a sum invested in the…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Down 29%, should I buy Palantir for my Stocks and Shares ISA?

Palantir Technologies has lost over a quarter of its value in the past few months. Does this make it a…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Selling for £1, are Lloyds shares still a bargain?

Lloyds shares sold for pennies for many years -- but now cost a pound. Our writer sees some strengths in…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

How much could spending just £5 a day on UK shares earn in passive income?

Sticking to UK shares in well-known companies, our writer shows how £5 a day could be used to target over…

Read more »

Dominos delivery man on skateboard holding pizza boxes
Investing Articles

Think you’re too young for a SIPP? Think again!

Is a SIPP something best left to later in working life? Not at all, according to this writer -- and…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

These 5 FTSE 100 shares all offer dividend yields well above average!

Christopher Ruane gives the lowdown on a handful of FTSE 100 shares, all yielding considerably higher than the index, that…

Read more »

Investing Articles

How to turn a Stocks and Shares ISA into £10k of annual passive income

Mark Hartley outlines a simple method of achieving a stable passive income stream from a Stocks and Shares ISA without…

Read more »